Caplin Point Laboratories Limited is a pharmaceutical company based in Chennai, India. Since its establishment in 1990, the company has been dedicated to developing, producing, marketing, and exporting a wide range of generic pharmaceutical formulations and branded products within India. Their product portfolio includes liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and various other pharmaceutical offerings. In addition to their pharmaceutical operations, Caplin Point Laboratories also operates an e-commerce website called QueTenX.
Navigation section
Caplin Point Laboratories Limited
- 2,200.00 92.65(4.40%) 2,201.00 93.80(4.45%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 2,099.90 2,101.95 | 2,200.00 2201.00 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 1,178.00 (13-Dec-2023) 1,179.95 (13-Dec-2023) | 2,200.00 (29-Nov-2024) 2,201.00 (29-Nov-2024) |
- Open
- 2,100.00 2,102.00
- Previous Close
- 2,107.35 2,107.20
- Volume
- 2.61
- Total Traded value
- 56.72 (₹ Lakhs)
- Upper circuit
- 2,528.80 1,725.80
- Lower circuit
- 1,685.90 1,150.60
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 64 | 0 |
| Bid Price | Quantity |
|---|---|
| 2,196.35 | 64.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 64 |
| Ask Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
Fundamentals
| Market Cap: | ₹167.23 Cr |
| PE Ratio (TTM): | 55.11 |
| PB Ratio: | 10.90 |
| Industry P/E: | 32.24 |
| Debt to Equity: | 0.0013 |
| ROE: | 19.78 |
| EPS (TTM): | 39.94 |
| Book Value: | 262.84 |
| Face Value: | 2.00 |
Financials
| Sep, 2022 | Sep, 2022 | Sep, 2023 | Jun, 2023 | Sep, 2023 | |
|---|---|---|---|---|---|
| Revenue | 1,354.42 Cr | 330.62 Cr | 101.92 Cr | 2,458.34 Cr | 179.22 Cr |
| Profit | 146.44 Cr | 17.51 Cr | 17.12 Cr | 386.90 Cr | 82.10 Cr |
| Expense | 1,187.88 Cr | 316.34 Cr | 123.46 Cr | - | 96.51 Cr |
| Comprehensive income | 147.51 Cr | 17.56 Cr | 17.12 Cr | - | 82.24 Cr |
| EPS | 7.45 | 7.65 | 2.25 | 5.77 | 10.76 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Caplin Point Laboratories Limited | Jun, 2014 Feb, 1995 | Pharmaceuticals Pharmaceuticals | CAPLIPOINT CAPLIPOINT |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Caplin Point Laboratories Limited FAQ's
What is the range of today's stock performance for Caplin Point Laboratories Limited?
Today's stock performance witnessed a fluctuation from a minimum of 2,099.90 on the NSE (National Stock Exchange) to a maximum of 2,200.00. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 2,101.95 to a high of 2,201.00.
What are the 52-week low and high values for Caplin Point Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 1,178.00 (occurred on 13-Dec-2023) and a high of 2,200.00 (achieved on 29-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,179.95 (on 13-Dec-2023), and the 52-week high is 2,201.00 (on 29-Nov-2024).
What was the opening and previous closing prices for Caplin Point Laboratories Limited?
The stock's performance over the past 52 weeks reveals a low of 1,178.00 (occurred on 13-Dec-2023) and a high of 2,200.00 (achieved on 29-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 1,179.95 (on 13-Dec-2023), and the 52-week high is 2,201.00 (on 29-Nov-2024).
What is the total volume and traded value for Caplin Point Laboratories Limited for the day?
The total volume is 3, and the total traded value is 56.72 (₹ Lakhs).
What are the upper and lower circuit limits for Caplin Point Laboratories Limited?
The upper circuit limit is 2,528.80, and the lower circuit limit is 1,685.90.
What is the market cap and PE ratio for Caplin Point Laboratories Limited?
The market cap is ₹167.23 Cr, and the PE ratio (TTM) is 32.24.
What is the PB ratio, industry P/E, and debt to equity ratio for Caplin Point Laboratories Limited?
The PB ratio is 8.37, industry P/E is 32.24 , and the debt to equity ratio is 0.0013.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Caplin Point Laboratories Limited?
ROE is 19.78, EPS is 39.94, book value is 262.84
What are the revenue and profit figures for the latest quarter and previous quarters for Caplin Point Laboratories Limited?
In Sep 2022, Revenue is ₹13544190000, and Profit is ₹1464430000. In Sep 2022, Revenue is ₹3306231000, and Profit is ₹175095000.
When was Caplin Point Laboratories Limited listed, and what industry does it belong to?
The company, Caplin Point Laboratories Limited, was listed in Jun 2014 and belongs to the Pharmaceuticals industry. Its NSE symbol is CAPLIPOINT.
What is the current shareholding pattern of the Caplin Point Laboratories Limited?
As of latest available update, promoters hold 70.63%, the public holds 29.37%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 25
- Threads
- 81
